[Importance of an antiseptic solution, Solubacter, in vulvo-vaginal infections].
Solubacter was prescribed, in combination with etiological treatment, for local application in 275 women with vulvovaginitis by 19 gynecologists in general practice as part of an open, multicentre study. The condition most frequently being treated was candidosis. A rapid improvement in vulvar symptoms was observed, right from the first few days of treatment. The treatment was well accepted by the patients and showed good tolerance, both in the judgement of the patients as well as that of the doctors. Solubacter thus proved to be a suitable additional aid in the treatment of vulvovaginitis.
Colau
J C
JC
Laboratoires Innothera, Arcueil.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002224:Carbanilides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D014848:Vulvovaginitis / Q000150:complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D002224:Carbanilides; C009540:triclocarban
Intérêt d'une solution antiseptique, Solubacter, dans les infections vulvo-vaginales.